Madrigal Pharmaceuticals Inc (MDGL)
200.67
+7.34
(+3.80%)
USD |
NASDAQ |
Apr 29, 15:24
Madrigal Pharmaceuticals Shares Outstanding: 19.90M for Feb. 22, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 22, 2024 | 19.90M |
December 31, 2023 | 19.88M |
November 01, 2023 | 19.74M |
October 03, 2023 | 19.72M |
September 30, 2023 | 18.49M |
August 03, 2023 | 18.47M |
July 31, 2023 | 18.47M |
June 30, 2023 | 18.46M |
May 05, 2023 | 18.29M |
April 27, 2023 | 18.28M |
March 31, 2023 | 18.28M |
February 20, 2023 | 18.14M |
December 31, 2022 | 18.10M |
December 19, 2022 | 17.84M |
November 01, 2022 | 17.10M |
September 30, 2022 | 17.10M |
August 01, 2022 | 17.10M |
June 30, 2022 | 17.10M |
May 05, 2022 | 17.10M |
April 27, 2022 | 17.10M |
March 31, 2022 | 17.10M |
February 21, 2022 | 17.10M |
December 31, 2021 | 17.10M |
November 02, 2021 | 17.10M |
September 30, 2021 | 16.86M |
Date | Value |
---|---|
July 30, 2021 | 16.60M |
June 30, 2021 | 16.60M |
April 30, 2021 | 16.58M |
April 26, 2021 | 16.49M |
April 01, 2021 | 16.49M |
March 31, 2021 | 16.06M |
February 19, 2021 | 16.02M |
December 31, 2020 | 15.51M |
October 30, 2020 | 15.47M |
September 30, 2020 | 15.47M |
July 31, 2020 | 15.44M |
June 30, 2020 | 15.44M |
May 04, 2020 | 15.43M |
April 24, 2020 | 15.43M |
April 01, 2020 | 15.43M |
March 31, 2020 | 15.43M |
February 21, 2020 | 15.43M |
December 31, 2019 | 15.43M |
December 01, 2019 | 15.43M |
November 01, 2019 | 15.43M |
October 11, 2019 | 15.43M |
October 01, 2019 | 15.43M |
September 30, 2019 | 15.43M |
August 01, 2019 | 15.43M |
June 30, 2019 | 15.43M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
15.42M
Minimum
May 02 2019
19.90M
Maximum
Feb 22 2024
16.80M
Average
16.60M
Median
Shares Outstanding Benchmarks
Eli Lilly and Co | 950.77M |
Viking Therapeutics Inc | 110.27M |
Akero Therapeutics Inc | 68.95M |
89bio Inc | 95.22M |
Geron Corp | 546.06M |